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In a logical sequence of progressively deduced propositions
and principles, Dr. Miettinen attempts to re-orient medical
academia to the theories underlying clinical research in his
recent book Up from Clinical Epidemiology & EBM
(Evidence Based Medicine) [1]. This ambitious avant-
garde text first examines the role of medical academia and
criticizes—perhaps too harshly at times—the current ways
of achieving knowledge about diagnosis, etiognosis, and
prognosis in clinical medicine. Currently lacking for cli-
nicians is an immediately applicable scientific knowledge
base of clinical practice. Instead, in the current clinical
epidemiology culture, practitioners are advised to spend
lengths of time critically appraising literature on particular
topics, form their own opinions on it, and use their
uncodified experiences and varying opinions to make
clinical decisions. The aim of EBM to standardize clinical
practice is stymied by the process currently required to
employ EBM. Exacerbating the problem are widespread
imperfections in designs of clinical studies. For these rea-
sons and others, Miettinen argues that EBM is a fallacy, ‘‘a
cult movement…at variance with the essence of science
and the imperatives of professionalism in medicine.’’
In place of current EBM, Miettinen suggests different
approaches to diagnosis, etiognosis, and prognosis—ones
that are arguably more valid and objective and that may
have the potential to bring major improvements to clinical
medicine. To construct a proper knowledge base for
clinical practice and offer it in a more directly usable form,
Miettinen proposes the construction and use of ‘gnostic
probability functions.’ These address the probability of an
illness being present, a risk factor having played a causal
role, or an untoward event happening in the course of an
illness as a function of diagnostic, etiognostic, or prog-
nostic indicators, respectively.
Miettinen develops in his book many new ideas about
diagnosis, so we focus our review mainly to these. In
support of diagnosis, Miettinen proposes that diagnostic
probability functions (DPF) be used instead of ‘reverse
probabilities’ (i.e., probabilities derived from comparing
past signs and symptoms in series of patients and non-
patients) and Bayes factors now commonly used in clinical
epidemiology. Miettinen describes a strategy of con-
structing DPF using codified tacit knowledge of experts.
We agree with Lubsen [2] that the description of this
strategy is one of the major contributions of the book.
Basically, panels of experts are presented with hypothetical
patient presentations and asked to attach a probability to
each scenario that a particular illness is present. Using the
responses from many experts, multiple logistic regression
analysis is then employed to model the probability of an
illness as a function of diagnostic indicators, which include
components of the risk profile (e.g., socio-demographic
factors) and manifestation profile (e.g., symptoms, signs,
and test results). The resulting model is incorporated into
software that allows users to estimate diagnostic proba-
bilities for real presenting patients. A derived method
provides for the evaluation of diagnostic tests as well. As
Miettinen states, ‘‘In this Information Age, the implication
is that the availability of user-friendly gnostic expert sys-
tems would enhance the efficiency of healthcare by
inherently contributing to both quality assurance and cost
containment in it.’’
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Assuming that valid DPF are defined for a wide enough
range of clinical scenarios, we too see the approach of
codifying experts’ tacit knowledge and the e-implementa-
tion of DPF as having great promise in supporting clinical
diagnosis, especially in settings where clinical expertise is
limited or inaccessible. However, a probability function
will be only as good as the data used to fit such a model.
We note that those data will be limited by the ability of
experts to recognize and accurately describe all aspects of
an illness process or presentation, and must be regularly
updated to accommodate evolving perspectives of disease
and continuous biomedical innovation. There may be a role
here for cloud-based artificial intelligence.
The scale of research efforts needed to construct such
detailed descriptions of diagnostic profiles and the chal-
lenges of implementing DPF seem so daunting that we are
sceptical about the practical nature of this great idea.
Moreover, it is unclear to us how well such models can
incorporate local effect-modifying circumstances as part of
the risk profile, or how useful they will be for atypical
clinical presentations. Yet even if the use of DPF is not
feasible for making refined diagnoses, we wonder about the
value of their application for the specific purpose of triage.
A major theme in Up from Clinical Epidemiology &
EBM is that several currently popular general study
designs—examples of which include the cohort, case–
control, and traditional diagnostic performance studies—
are fallacies. This theme has also dominated many of
Miettinen’s previous writings. We agree with him that
classical cohort studies fail to see etiologic time as inher-
ently negative; that classical case–control approaches fail
to define the reference series from the study base; and that
traditional diagnostic studies are limited by their reverse
orientation and inability to clearly define a study domain.
For Miettinen these imperfections, together with his view
that particularistic studies are not scientific and not even
research, seem to imply the need for a tabula rasa approach,
a blank slate. Consequently, the range of general study
designs considered in this book is narrower than what
many readers will expect.
Readers should be advised that reading this book is a
serious undertaking, and we recommend using Miettinen’s
other recent book Epidemiological Research: Terms and
Concepts [3–5] in support. By questioning widely held
assumptions and using logical deductive reasoning,
Miettinen invokes his Socratic nature and confirms his
great strength as a theoretical epidemiologist. We highly
recommend this fascinating book to all epidemiologists
and look forward to the much-needed discourse on its
content.
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